Doctor profile · Federal record

Dr. Blake Galler, D.O.

Dermatology Physician (CMS: Dermatology) · Wasilla, AK

  • NPI 1265705933
  • Accepts Medicare
  • MIPS 45.1 / 100 · 2023
  • 14 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
3066 E Meridian Park Loop
Wasilla, AK 996547254
(907) 357-9590
fax (907) 357-9593
Additional location
1100 E Dimond Blvd Ste 103
Anchorage, AK 995152001
(907) 267-5890
fax (844) 670-3889
Mailing address
3000 Custer RD Ste 270
Plano, TX 750754427

Credentials & registration

NPPES · NUCC
NPI registered
February 2012 — 14 yrs on file
Profile last updated
September 29, 2025
Year of graduation
2012 — 14 yrs since
Specialty taxonomy
207N00000X — NUCC code
State license (1)
Alaska #115179

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1265705933. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
4,530
Distinct HCPCS
10
Medicare allowed
$577,784
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 667 151 $8
G6001 Ultrasonic guidance for placement of radiation therapy fields 531 35 $205
77280 Obtaining data needed to develop the optimal radiation treatment, 1 treatment area 504 34 $305
77401 Superficial and/or low voltage radiation treatment delivery 484 34 $45
99213 Established patient office or other outpatient visit, 20-29 minutes 351 254 $113
99203 New patient office or other outpatient visit, 30-44 minutes 337 337 $139
17000 Destruction of precancer skin growth, 1 growth 259 228 $54
11102 Biopsy of related skin growth, first growth 251 235 $105
11103 Biopsy of related skin growth, each additional growth 249 103 $60
17110 Destruction of skin growth, 1-14 growths 229 201 $129

In context: peer comparison

Among 1 peers in Wasilla Dermatology Physician, average services per provider: 174. This provider delivers 26× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,121
Transactions
64
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Janssen Biotech, INC. 8 $413.74
Arcutis Biotherapeutics, INC. 10 $337.32
Lilly USA, LLC 15 $272.37
Sanofi-Aventis U.S. LLC 6 $256.47
E.R. Squibb & Sons, L.L.C. 8 $178.81
Leo Pharma INC. 2 $113.28
Amgen INC. 4 $101.56
Dermavant Sciences, INC. 2 $97.33
Galderma Laboratories, L.P. 1 $68.72
Tandem Diabetes Care, INC. 2 $48.34
Blueprint Medicines Corporation 1 $33.28
Abbvie INC. 2 $31.30
Dexcom, INC. 1 $29.65
Genzyme Corporation 1 $28.61
Bayer Healthcare Pharmaceuticals INC. 1 $26.02

By nature of payment

Food and Beverage
$1,831
Education
$290

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
484
Patients
315
Total drug cost
$173,161
Drug Type Claims Patients Total cost
Ketoconazole Generic 173 110 $2,816
Clobetasol Propionate Generic 47 32 $1,853
Triamcinolone Acetonide Generic 46 34 $434
Clotrimazole Generic 44 34 $959
Imiquimod Generic 30 17 $1,177
Doxycycline Hyclate Generic 26 19 $573
Fluorouracil Generic 25 22 $1,964
Clotrimazole-Betamethasone (Clotrimazole/Betamethasone Dip) Brand 22 19 $479
Terbinafine Hcl Generic 21 17 $239
Clindamycin Phosphate Generic 18 11 $342

Frequently asked questions

Auto-generated from federal data
What is Dr. Blake Galler's medical specialty?
Dr. Blake Galler practices Dermatology Physician in Wasilla, AK.
Where does Dr. Blake Galler practice?
Dr. Blake Galler practices at 3066 E Meridian Park Loop, Wasilla, AK 996547254. Office phone: 9073579590.
What is Dr. Blake Galler's NPI?
Dr. Blake Galler's National Provider Identifier (NPI) is 1265705933, issued by NPPES.
Does Dr. Blake Galler accept Medicare assignment?
Yes. Dr. Blake Galler accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Blake Galler commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Ultrasonic guidance for placement of radiation therapy fields (HCPCS G6001); Obtaining data needed to develop the optimal radiation treatment, 1 treatment area (HCPCS 77280). Source: CMS Medicare Physician & Other Practitioners file.